申请人:GLAXOSMITHKLINE LLC
公开号:US20130072690A1
公开(公告)日:2013-03-21
Disclosed are compounds of Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.
本发明公开了III式化合物。本发明还公开了该化合物的盐、包含该化合物或盐的药物组合物以及通过给予该化合物或盐治疗HCV感染的方法。